128 related articles for article (PubMed ID: 37918820)
1. Tumor Microenvironment Modulating CaCO
Dong Z; Liu Y; Wang C; Hao Y; Fan Q; Yang Z; Li Q; Feng L; Liu Z
Adv Mater; 2024 Mar; 36(9):e2308254. PubMed ID: 37918820
[TBL] [Abstract][Full Text] [Related]
2. Chemical Modulation of Glucose Metabolism with a Fluorinated CaCO
Dong Z; Wang C; Gong Y; Zhang Y; Fan Q; Hao Y; Li Q; Wu Y; Zhong X; Yang K; Feng L; Liu Z
ACS Nano; 2022 Sep; 16(9):13884-13899. PubMed ID: 36075132
[TBL] [Abstract][Full Text] [Related]
3. Nanoenabled Modulation of Acidic Tumor Microenvironment Reverses Anergy of Infiltrating T Cells and Potentiates Anti-PD-1 Therapy.
Zhang YX; Zhao YY; Shen J; Sun X; Liu Y; Liu H; Wang Y; Wang J
Nano Lett; 2019 May; 19(5):2774-2783. PubMed ID: 30943039
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.
Wang D; Jiang W; Zhu F; Mao X; Agrawal S
Int J Oncol; 2018 Sep; 53(3):1193-1203. PubMed ID: 29956749
[TBL] [Abstract][Full Text] [Related]
5. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
6. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
7. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
[TBL] [Abstract][Full Text] [Related]
8. A Lactate-Depleting metal organic framework-based nanocatalyst reinforces intratumoral T cell response to boost anti-PD1 immunotherapy.
Zhou J; Hu Y; Cao Y; Ding S; Zeng L; Zhang Y; Cao M; Duan G; Zhang X; Bian XW; Tian G
J Colloid Interface Sci; 2024 Apr; 660():869-884. PubMed ID: 38277843
[TBL] [Abstract][Full Text] [Related]
9. An Injectable Puerarin Depot Can Potentiate Chimeric Antigen Receptor Natural Killer Cell Immunotherapy Against Targeted Solid Tumors by Reversing Tumor Immunosuppression.
Liu Y; Hao Y; Chen J; Chen M; Tian J; Lv X; Zhang Y; Ma X; Zhou Y; Feng L
Small; 2024 Jan; ():e2307521. PubMed ID: 38212279
[TBL] [Abstract][Full Text] [Related]
10. Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors.
Yuan X; Sun Z; Yuan Q; Hou W; Liang Q; Wang Y; Mo W; Wang H; Yu M
Invest New Drugs; 2021 Feb; 39(1):34-51. PubMed ID: 32772342
[TBL] [Abstract][Full Text] [Related]
11. Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression.
Finisguerra V; Dvorakova T; Formenti M; Van Meerbeeck P; Mignion L; Gallez B; Van den Eynde BJ
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37147018
[TBL] [Abstract][Full Text] [Related]
12. Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors.
Jan CI; Huang SW; Canoll P; Bruce JN; Lin YC; Pan CM; Lu HM; Chiu SC; Cho DY
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34663641
[TBL] [Abstract][Full Text] [Related]
13. Coordination Polymer-Coated CaCO
Wang C; Dong Z; Hao Y; Zhu Y; Ni J; Li Q; Liu B; Han Y; Yang Z; Wan J; Yang K; Liu Z; Feng L
Adv Mater; 2022 Jan; 34(3):e2106520. PubMed ID: 34773309
[TBL] [Abstract][Full Text] [Related]
14. Acidic/hypoxia dual-alleviated nanoregulators for enhanced treatment of tumor chemo-immunotherapy.
Guo X; Chen X; Ding J; Zhang F; Chen S; Hu X; Fang S; Shen L; Lu C; Zhao Z; Tu J; Shu G; Chen M; Ji J
Asian J Pharm Sci; 2024 Apr; 19(2):100905. PubMed ID: 38595332
[TBL] [Abstract][Full Text] [Related]
15. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
[TBL] [Abstract][Full Text] [Related]
16. Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma.
Hou G; Qian J; Guo M; Xu W; Wang J; Wang Y; Suo A
J Colloid Interface Sci; 2022 Dec; 628(Pt B):968-983. PubMed ID: 36037718
[TBL] [Abstract][Full Text] [Related]
17. A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacy.
Zhang Z; Wang G; Zhong K; Chen Y; Yang N; Lu Q; Yuan B; Wang Z; Li H; Guo L; Zhang R; Wu Z; Zheng M; Zhao S; Tang X; Shao B; Tong A
J Transl Med; 2023 Jan; 21(1):23. PubMed ID: 36635683
[TBL] [Abstract][Full Text] [Related]
18. Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy.
Das S; Valton J; Duchateau P; Poirot L
Front Immunol; 2023; 14():1172681. PubMed ID: 37251405
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-integrated dissolving microneedles for the co-delivery of R848/aPD-1 to synergistically reverse the immunosuppressive microenvironment of triple-negative breast cancer.
Huang S; Wen T; Wang J; Wei H; Xiao Z; Li B; Shuai X
Acta Biomater; 2024 Mar; 176():344-355. PubMed ID: 38244662
[TBL] [Abstract][Full Text] [Related]
20. Liposomal oxaliplatin prodrugs loaded with metformin potentiate immunotherapy for colorectal cancer.
Song L; Hao Y; Wang C; Han Y; Zhu Y; Feng L; Miao L; Liu Z
J Control Release; 2022 Oct; 350():922-932. PubMed ID: 36108810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
